$474.00
Avam® RNase A Inhibitor is an indispensable tool for safeguarding RNA integrity in molecular biology applications. With its potent inhibitory action against pancreatic-type ribonucleases A, B, and C, this recombinant acidic protein, weighing 52 kDa, offers robust protection against RNA degradation. It is specifically designed as a non-competitive inhibitor, allowing it to bind with high affinity to targeted RNases without affecting other modifying enzymes like polymerases and reverse transcriptases. Supplied in a stable solution containing 20 mM Hepes-KOH, 50 mM KCI, 8 mM DTT, and 50% glycerol, with a pH of 7.5 at 25°C, this RNase Inhibitor ensures RNA stability throughout experimental procedures.
● Avam® RNase A Inhibitor enzyme (20,000 U concentration)
● Purity: >99%
● Specific Activity: 53,333 U/mg
● Single-stranded exonuclease: <5.0% released
● Double-stranded exonuclease: <1.0% released
● Double-stranded endonuclease: No conversion
● E. coli DNA contamination: <10 copies
● RNase contamination: No detectable non-specific RNase
Avam® RNase A Inhibitor is essential for applications where RNase presence
may affect RNA quality and experimental results, including:
● RNA isolation and purification
● cDNA synthesis
● RT-PCR and RT-qPCR
● In vitro transcription and translation
● RNase-free monoclonal antibody production
It should be stored at -25°C to -15°C for long-term stability and activity.
It inhibits pancreatic-type ribonucleases A, B, and C by binding non-covalently with high affinity in a 1:1 ratio, effectively preventing RNA degradation.
Yes, it does not interfere with the activities of other RNases or modifying enzymes like polymerases and reverse transcriptases.
Unit activity, protein concentration, physical purity, single-stranded exonuclease, double-stranded exonuclease, double-stranded endonuclease, and E. coli contamination are rigorously evaluated to ensure high quality and performance consistency.
Quantity | 20000U |
---|